Skip to main content

Search

User account menu

IRBManager
CTSU

Main navigation

Home
About
For New Users
For Institutions
For Networks
For Board Members
Contact Us

AOST1321

Phase II Study of Denosumab (IND #127430; NSC# 744010); a RANK Ligand Antibody; for Recurrent or Refractory Osteosarcoma

Available to Open

401 N. Washington Street, Ste. 700
Rockville, MD 20850

The Central Institutional Review Board for the National Cancer of Institute is fully accredited by the Association for the Accreditation of Human Research Protection Program, Inc.